How does hydrogen therapy work against cancer?

Hydrogen therapy works through a dual mechanism - it creates toxic conditions that kill cancer cells while simultaneously protecting and activating immune cells. This allows the body's natural defenses to better fight the cancer.

What makes this hydrogen cancer treatment different?

Unlike traditional treatments that suppress the immune system, this hydrogen therapy enhances immune function while directly attacking cancer cells. It uses light-activated nanosheets to deliver hydrogen precisely to tumor sites.

Is hydrogen therapy safe for cancer patients?

This study was conducted in cell cultures, so human safety data is not yet available. However, the research shows hydrogen protects healthy immune cells from damage while targeting cancer cells specifically.

Can hydrogen boost the immune system against cancer?

Yes, this study found hydrogen enhanced dendritic cell maturation, increased T-cell infiltration into tumors, and reprogrammed immune-suppressing environments. This helps the immune system better recognize and attack cancer cells.

How is hydrogen delivered in this cancer treatment?

Researchers used special nanosheets loaded with hydrogen that release the gas when activated by near-infrared light. This allows precise control over where and when the hydrogen is delivered to cancer cells.

Hydrogen Therapy Fights Cancer by Boosting Immune System

Authors: Hongyu Chu, Qiong Wu, Zhonghang Xu, Jingrui Cao, Hanyue Zheng, Jiandong Wu, Qihui Liu, Xiaowen Ruan, Xuedong Fang, Xiaoqiang Cui, Sai Kishore Ravi, Fangfang Chen
Journal: Acta Biomaterialia
Year: 2025
DOI: 10.1016/j.actbio.2025.10.059
Study Type: Cell Culture
Outcome: Positive
Peer Reviewed: Yes
Country: China
Health Condition: Cancer
Body System: Immune System

TL;DR

Hydrogen released from RhPd-H nanosheets under NIR light selectively induces tumor cell death while protecting and activating immune cells—offering precise redox control for cancer immunotherapy.

Key Finding

Hydrogen released from a specially designed nanosheet platform simultaneously triggered cancer cell death through oxidative stress while protecting and activating immune cells against the same type of damage, suggesting a selective targeting mechanism.

Summary

Researchers developed a nanosheet platform containing hydrogen that releases hydrogen gas when exposed to near-infrared light. In cell culture experiments, this system had a dual effect: it generated harmful molecules (reactive oxygen species) that killed cancer cells, while simultaneously protecting immune cells from damage and activating them to fight tumors. The approach combined heat therapy with hydrogen's chemical properties to both directly kill cancer cells and reprogram the immune environment around tumors.

Practical Takeaway

This is early-stage cell culture research using a specialized nanosheet delivery system activated by near-infrared light—not hydrogen water or gas inhalation. The findings are preliminary and have not been tested in animals or humans. While the dual-action mechanism is scientifically interesting, it's unclear whether similar effects would occur with other forms of hydrogen delivery or in living organisms.

Abstract

Photothermal-catalysis enables controlled hydrogen release and redox modulation, with applications in biomedical therapy. Despite growing interest in hydrogen therapy, its effects on immune cells within the tumor microenvironment (TME) remain insufficiently elucidated, specifically regarding selective redox modulation and immune activation. Herein, we present H atoms stabilize the rhodium palladium bimetallene (RhPd-H) nanosheets as a hydrogen-loaded photothermal-catalytic platform with NIR-triggered release for targeted redox modulation in TME. Upon NIR irradiation, RhPd-H serves as a dual-source of hydrogen and localized heat, inducing reactive oxygen species (ROS) bursts that selectively disrupt tumor redox homeostasis, leading to apoptosis of tumor cells. Synergistically, hydrogen scavenges ROS in immune cells, protecting them from oxidative stress and further promoting dendritic cell maturation, T-cell activation, and macrophage polarizaion for exerting anti-tumor effects. Experimental data reveals the synergy of hydrogen-photothermal therapy in ablating tumors and reprograming the immunosuppressive TME, as evidenced by enhanced antigen presentation, amplified T-cell infiltration and systemic anti-tumor memory responses. Particularly, we report the novel finding that hydrogen performs both protective and activating effects on immune cells, which to our knowledge has not been previously documented, revealing a veil of mystery of hydrogen therapy. By integrating hydrogen-mediated redox editing and immunomodulation, this work establishes a paradigm-shifting strategy for precise tumor therapy. STATEMENT OF SIGNIFICANCE: This work unveils a paradigm-shifting duality of hydrogen (H₂) within the tumor microenvironment: simultaneously acting as a pro-oxidative inducer of reactive oxygen species (ROS) bursts in tumor cells while serving as a protective antioxidant and immunomodulator in immune cells. Under NIR irradiation, H₂ released from hydrogen-stabilized rhodium-palladium bimetallene (RhPd-H) nanosheets synergizes with photothermal energy to disrupt redox homeostasis and trigger selective apoptosis in tumors. Concurrently, in immune cells, H₂ scavenges photothermal-induced ROS-shielding them from oxidative damage while activating dendritic cell maturation, cytotoxic T-cell infiltration, and macrophage polarization toward antitumor phenotypes. This cell-contextual redox switching not only ablates tumors directly but also reprograms the immunosuppressive microenvironment, revealing an unprecedented biological mechanism for hydrogen therapy and establishing differential redox editing as a transformative strategy for precision cancer treatment.